JP5534988B2 - Granular bath agent composition - Google Patents
Granular bath agent composition Download PDFInfo
- Publication number
- JP5534988B2 JP5534988B2 JP2010158924A JP2010158924A JP5534988B2 JP 5534988 B2 JP5534988 B2 JP 5534988B2 JP 2010158924 A JP2010158924 A JP 2010158924A JP 2010158924 A JP2010158924 A JP 2010158924A JP 5534988 B2 JP5534988 B2 JP 5534988B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- fatty acid
- oil
- bath
- preferable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 39
- 239000013040 bath agent Substances 0.000 title claims description 34
- -1 fatty acid ester Chemical class 0.000 claims description 78
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 54
- 239000000194 fatty acid Substances 0.000 claims description 54
- 229930195729 fatty acid Natural products 0.000 claims description 54
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 29
- 239000002736 nonionic surfactant Substances 0.000 claims description 28
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 17
- 229910052751 metal Inorganic materials 0.000 claims description 17
- 239000002184 metal Substances 0.000 claims description 17
- 239000008187 granular material Substances 0.000 claims description 16
- 150000007524 organic acids Chemical class 0.000 claims description 14
- 239000003232 water-soluble binding agent Substances 0.000 claims description 14
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 9
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 6
- 150000005215 alkyl ethers Chemical class 0.000 claims description 6
- 239000000600 sorbitol Substances 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 239000004359 castor oil Substances 0.000 claims description 5
- 235000019438 castor oil Nutrition 0.000 claims description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 86
- 239000001569 carbon dioxide Substances 0.000 description 43
- 229910002092 carbon dioxide Inorganic materials 0.000 description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 36
- 239000003921 oil Substances 0.000 description 31
- 235000019198 oils Nutrition 0.000 description 31
- 239000002245 particle Substances 0.000 description 29
- 239000007789 gas Substances 0.000 description 22
- 230000000694 effects Effects 0.000 description 19
- 238000000034 method Methods 0.000 description 15
- 238000003287 bathing Methods 0.000 description 14
- 238000005187 foaming Methods 0.000 description 14
- 230000009102 absorption Effects 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 12
- 239000003788 bath preparation Substances 0.000 description 11
- 239000006260 foam Substances 0.000 description 9
- 238000005259 measurement Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 238000001179 sorption measurement Methods 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 230000035515 penetration Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- 238000009826 distribution Methods 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 235000019830 sodium polyphosphate Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 description 2
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 125000005313 fatty acid group Chemical group 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- ZUBZATZOEPUUQF-UHFFFAOYSA-N isononane Chemical compound CCCCCCC(C)C ZUBZATZOEPUUQF-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 235000012245 magnesium oxide Nutrition 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- ZAZKJZBWRNNLDS-UHFFFAOYSA-N methyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC ZAZKJZBWRNNLDS-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000010666 rose oil Substances 0.000 description 2
- 235000019719 rose oil Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- BODMYPYTCKYRSP-UHFFFAOYSA-N 1,1-dioctylcyclohexane Chemical compound CCCCCCCCC1(CCCCCCCC)CCCCC1 BODMYPYTCKYRSP-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- FVKRIDSRWFEQME-UHFFFAOYSA-N 3-methylbutyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCC(C)C FVKRIDSRWFEQME-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- NDKYEUQMPZIGFN-UHFFFAOYSA-N Butyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCC NDKYEUQMPZIGFN-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 206010016334 Feeling hot Diseases 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 235000000665 Lycianthes asarifolia Nutrition 0.000 description 1
- 241000866517 Lycianthes asarifolia Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 241001529735 Melissa Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 235000014426 Schisandra repanda Nutrition 0.000 description 1
- 240000001315 Schisandra repanda Species 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000010639 cypress oil Substances 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- LRMHFDNWKCSEQU-UHFFFAOYSA-N ethoxyethane;phenol Chemical compound CCOCC.OC1=CC=CC=C1 LRMHFDNWKCSEQU-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940074050 glyceryl myristate Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229940078565 isoamyl laurate Drugs 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 description 1
- 229940073769 methyl oleate Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 229940062000 polyglyceryl-2 triisostearate Drugs 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000010675 spruce oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- JREYOWJEWZVAOR-UHFFFAOYSA-N triazanium;[3-methylbut-3-enoxy(oxido)phosphoryl] phosphate Chemical compound [NH4+].[NH4+].[NH4+].CC(=C)CCOP([O-])(=O)OP([O-])([O-])=O JREYOWJEWZVAOR-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、粒状浴用剤組成物、特に、発泡性の粒状浴用剤組成物に関する。 The present invention relates to a granular bath agent composition, and more particularly to a foamable granular bath agent composition.
炭酸塩と有機酸を配合した浴用剤は、浴水中で炭酸ガスの泡を発生し、当該炭酸ガスによる血行促進効果が得られることから、優れた浴用剤として広く知られている。このような浴用剤においては、浴水中で発生した炭酸ガスの濃度を高める手段として、浴槽の底部付近で浴用剤を溶解させるために、その形態を粒状ではなく、比較的大型の錠剤型とすることが多い。 A bath agent containing a carbonate and an organic acid is widely known as an excellent bath agent because it generates bubbles of carbon dioxide gas in the bath water and the blood circulation promoting effect by the carbon dioxide gas is obtained. In such a bath preparation, as a means for increasing the concentration of carbon dioxide gas generated in the bath water, in order to dissolve the bath preparation in the vicinity of the bottom of the bathtub, the form is not granular but a relatively large tablet type. There are many cases.
浴用剤の他の形態である粒状発泡性浴用剤は、打錠等の特殊な製造技術を必要としないこと、一般に溶解時間が短いこと等から、使用状態や好みにより錠剤型と使い分けられており、種々の研究がなされている。例えば、発泡性と保存安定性のために特定の含有量で油性成分を配合して一定の平均粒子径範囲の顆粒とする技術(特許文献1)が報告されている。 The granular foaming bath agent, which is another form of bath agent, does not require special manufacturing technology such as tableting, and generally has a short dissolution time, so it is used separately from the tablet type depending on the usage condition and preference. Various studies have been conducted. For example, a technique (Patent Document 1) has been reported in which an oily component is blended with a specific content for foaming properties and storage stability to form granules having a certain average particle size range.
一方、入浴による肌からの油分の喪失の防止、入浴後の肌のかさつき防止ためには、浴用剤に油性成分を配合することが一般的である。例えば、肌感触が良好で入浴後の温まり感を向上させるために、炭酸ガス発生物と特定の油性成分等を併用した浴用剤組成物(特許文献2)が知られている。また、特定の脂肪酸エステルを含有した炭酸浴によるスキンケア方法(特許文献3)も知られている。 On the other hand, in order to prevent the loss of oil from the skin due to bathing and to prevent the skin from becoming bulky after bathing, it is common to add an oil component to the bath preparation. For example, a bath agent composition (Patent Document 2) that uses a carbon dioxide gas generation product and a specific oil component in combination in order to improve the feeling of warmth after bathing and having a good skin feel is known. A skin care method using a carbonated bath containing a specific fatty acid ester (Patent Document 3) is also known.
しかしながら、従来の粒状浴用剤には液状浴用剤のように油性成分を多量に配合することはできず、そのスキンケア効果については、依然検討の余地があった。
従って本発明の課題は、入浴後の皮膚に対してしっとり感を著しく持続させ、優れたスキンケア効果を発揮する粒状発泡性浴用剤を提供することにある。
However, conventional granular bath preparations cannot contain a large amount of oily components like liquid bath preparations, and their skin care effects still have room for investigation.
Accordingly, an object of the present invention is to provide a granular foaming bath agent that significantly maintains a moist feeling on the skin after bathing and exhibits an excellent skin care effect.
そこで本発明者らは前記課題を解決すべく鋭意検討を行ったところ、有機酸を非イオン界面活性剤、水溶性バインダー及び特定のClogP値を有する脂肪酸エステルとともに造粒物とし、一方炭酸塩については炭酸ジアルカリ金属塩と炭酸水素塩の含有量を調整し、当該造粒物と炭酸塩とを組み合せて用いれば、浴水中で発生する炭酸ガスの泡を極めて微細なものにすることができ、脂肪酸エステルの皮膚への吸着や浸透が著しく促進され、その結果、従来の粒状浴用剤や錠剤状浴用剤と比較して極めて優れたしっとり感を持続させる効果を有する粒状浴用剤組成物が得られることを見出し、本発明を完成した。 Therefore, the present inventors conducted extensive studies to solve the above-mentioned problems. As a result, the organic acid was granulated together with a nonionic surfactant, a water-soluble binder, and a fatty acid ester having a specific ClogP value. Adjusts the content of dialkali metal carbonate and hydrogen carbonate, and if the granulated product and carbonate are used in combination, the bubbles of carbon dioxide generated in the bath water can be made extremely fine, The absorption and penetration of fatty acid ester into the skin is significantly promoted, and as a result, a granular bath composition having an excellent effect of maintaining a moist feeling compared to conventional granular bath preparations and tablet bath preparations can be obtained. As a result, the present invention has been completed.
すなわち、本発明は、次の成分(A)並びに(B):
(A)有機酸、分子量が100以上でありClogP値が4〜18である脂肪酸エステル、非イオン界面活性剤及び水溶性バインダーを含む造粒物、並びに
(B)炭酸ジアルカリ金属塩を含有し、且つ、炭酸水素塩を70質量%以下含有する炭酸塩
を含有する粒状浴用剤組成物を提供するものである。
That is, the present invention includes the following components (A) and (B):
(A) an organic acid, a granule containing a fatty acid ester having a molecular weight of 100 or more and a ClogP value of 4 to 18, a nonionic surfactant and a water-soluble binder, and (B) containing a dialkali metal carbonate, And the granular bath agent composition containing the carbonate containing 70 mass% or less of hydrogencarbonate is provided.
本発明の粒状浴用剤組成物を浴水に投入して入浴すれば、微細な炭酸ガスの泡が多量に発生するため浴後に優れた温まり感が得られるのみならず、脂肪酸エステルの皮膚への吸着量や浸透量が著しく向上するため、浴後の過乾燥を抑制でき、その結果、著しく高いしっとり感を持続させる効果が得られる。 If the granular bath preparation composition of the present invention is poured into bath water and bathed, a large amount of fine carbon dioxide bubbles are generated, so that not only an excellent warm feeling after bathing is obtained, but also fatty acid esters on the skin. Since the adsorption amount and the penetration amount are remarkably improved, overdrying after the bath can be suppressed, and as a result, an effect of maintaining a remarkably high moist feeling can be obtained.
本発明の粒状浴用剤組成物に含まれる成分(A)は、(a1)有機酸、(a2)分子量が100以上でありClogP値が4〜18である脂肪酸エステル、(a3)非イオン界面活性剤及び(a4)水溶性バインダーを含有する造粒物である(以下、造粒物(A)ともいう)。 Component (A) contained in the granular bath agent composition of the present invention comprises (a1) an organic acid, (a2) a fatty acid ester having a molecular weight of 100 or more and a ClogP value of 4 to 18, and (a3) a nonionic surface activity. And (a4) a granulated product containing a water-soluble binder (hereinafter also referred to as granulated product (A)).
本発明で用いる(a1)有機酸は、浴水中での溶解性及び製造時や使用時のハンドリング性の観点から、水溶性、かつ常温(20℃)で固体のものが好ましい。また、油性成分である脂肪酸エステルを造粒物中に安定に配合し微細発泡を良好に進行させ高いしっとり感持続効果を奏する観点から、吸油能が0.02mL/g以上のものが好ましく、0.05mL/g以上のものがより好ましい。吸油能とは、後述する実施例に記載の方法により決定される値である。尚、吸油能の上限は、粒子強度の観点から1.0mL/g以下であることが望ましい。 The organic acid (a1) used in the present invention is preferably water-soluble and solid at room temperature (20 ° C.) from the viewpoints of solubility in bath water and handling during production and use. From the viewpoint of stably blending the fatty acid ester, which is an oily component, into the granulated product and promoting fine foaming to achieve a high moist feeling sustaining effect, an oil absorption capacity of 0.02 mL / g or more is preferable. More preferable is 0.05 mL / g or more. The oil absorption capacity is a value determined by the method described in Examples described later. The upper limit of oil absorption capacity is desirably 1.0 mL / g or less from the viewpoint of particle strength.
有機酸としては、コハク酸、フマル酸、リンゴ酸、アジピン酸、酒石酸、安息香酸、クエン酸、ピロリドンカルボン酸、サリチル酸等が好ましい。泡の微細化や発泡性を良好にして高いしっとり感持続効果を奏する観点や、ハンドリングの容易さ及び経済性の観点から、フマル酸が特に好ましい。これら有機酸は、単独又は2種以上を適宜組み合わせて用いることができる。 As the organic acid, succinic acid, fumaric acid, malic acid, adipic acid, tartaric acid, benzoic acid, citric acid, pyrrolidone carboxylic acid, salicylic acid and the like are preferable. Fumaric acid is particularly preferable from the viewpoints of improving the fineness and foamability of the foam and achieving a high moist feeling sustaining effect, and ease of handling and economy. These organic acids can be used alone or in combination of two or more.
造粒物(A)中の有機酸の含有量は、40〜95質量%が好ましく、70〜90質量%がより好ましい。この範囲内であると、泡の微細化や発泡性が良好で、脂肪酸エステルを含む油性成分を安定的に配合し高いしっとり感持続効果が得られるため好ましい。また、造粒物の保形性を保つ観点から、この範囲内が好ましい。 40-95 mass% is preferable and, as for content of the organic acid in granulated material (A), 70-90 mass% is more preferable. Within this range, it is preferable because the fineness of foam and foamability are good, and an oily component containing a fatty acid ester is stably blended to obtain a high moist feeling sustaining effect. Moreover, the range within this range is preferable from the viewpoint of maintaining the shape retention of the granulated product.
本発明で用いる(a2)分子量が100以上でありClogP値が4〜18である脂肪酸エステルは、造粒物(A)の浴水中への溶解性を制御し、泡の微細化や発泡性に有効に作用すると共に、浴水中で発生した炭酸ガスを、浴水だけでなく、当該脂肪酸エステル中にも分配させることで、高濃度の炭酸ガスを皮膚に供給し、血行促進効果を高める作用を有する。さらに、本発明において(a2)脂肪酸エステルは、微細な炭酸ガスの泡とともに皮膚に接触することにより、皮膚への吸着量及び浸透量が顕著に増加するため、入浴後の皮膚に対してしっとり感を著しく持続させ、優れたスキンケア効果を発揮する。
ここで、ClogP値は.A.Leo Comprehensive Medicinal Chemistry,Vol.4 C.Hansch、P.G.Sammens,J.B Taylor and C.A.Ramsden,Eds.,P.295,Pergamon Press,1990に記載の方法で計算した“計算logP(ClogP)”であり、プログラムCLOGP v4.01により計算したClogP値である。
The fatty acid ester (a2) having a molecular weight of 100 or more and a ClogP value of 4 to 18 used in the present invention controls the solubility of the granulated product (A) in the bath water, and makes the foam finer and foamable. In addition to acting effectively, the carbon dioxide gas generated in the bath water is distributed not only in the bath water but also in the fatty acid ester, thereby supplying a high concentration of carbon dioxide gas to the skin and enhancing the blood circulation promoting effect. Have. Furthermore, in the present invention, the fatty acid ester (a2) comes into contact with the skin together with fine carbon dioxide bubbles, so that the amount of adsorption and penetration into the skin is remarkably increased. Remarkably lasts and exhibits an excellent skin care effect.
Here, the ClogP value is. A. Leo Comprehensive Medicinal Chemistry, Vol. 4 C.I. Hansch, P.A. G. Sammens, J .; B Taylor and C.M. A. Ramsden, Eds. , P.M. 295, Pergamon Press, 1990, “calculated logP (ClogP)”, which is a ClogP value calculated by the program CLOGP v4.01.
好ましい(a2)脂肪酸エステルとしては、総炭素数8〜40の脂肪酸エステルが挙げられ、炭素数6〜20の脂肪酸基と炭素数2〜18のアルキル基を有するエステルが好ましく、特に炭素数6〜20の脂肪酸基と炭素数2〜16のアルキル基を有するエステルがより好ましい。具体的にはオクタン酸セチル、イソオクタン酸セチル、ラウリン酸ブチル、ラウリン酸イソアミル、ミリスチン酸メチル、ミリスチン酸エチル、ミリスチン酸イソプロピル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸エチル、ステアリン酸ブチル、イソノナン酸イソトリデシル、イソノナン酸イソノニル、リノール酸イソプロピル、イソステアリン酸イソプロピル、オレイン酸メチル、オレイン酸エチル等が挙げられる。また、分子内に脂肪酸エステル構造を有するトリ(カプリル酸・カプリン酸)グリセリン、トリカプリル酸グリセリル等の脂肪酸グリセリド類;イソステアリン酸ポリグリセリル−2、トリイソステアリン酸ポリグリセリル−2等の脂肪酸ポリグリセリド類;大豆油、ヌカ油、ホホバ油、アボガド油、アーモンド油、オリーブ油、カカオ脂、ゴマ油、パーシック油、ヒマシ油、ヤシ油、ミンク油、牛脂、豚脂等の天然油脂、これらの天然油脂を水素添加して得られる硬化油及びミリスチン酸グリセリル、2−エチルヘキサン酸グリセリル等のグリセリド類等も挙げられる。これらの脂肪酸エステルは単独で、又は2種以上を組み合せて使用できる。 Preferable (a2) fatty acid esters include fatty acid esters having a total carbon number of 8 to 40, and esters having a fatty acid group having 6 to 20 carbon atoms and an alkyl group having 2 to 18 carbon atoms are preferred, and particularly 6 to 6 carbon atoms. An ester having 20 fatty acid groups and an alkyl group having 2 to 16 carbon atoms is more preferred. Specifically, cetyl octanoate, cetyl isooctanoate, butyl laurate, isoamyl laurate, methyl myristate, ethyl myristate, isopropyl myristate, octyldodecyl myristate, isopropyl palmitate, ethyl stearate, butyl stearate, isononane Examples include isotridecyl acid, isononyl isononanoate, isopropyl linoleate, isopropyl isostearate, methyl oleate, and ethyl oleate. In addition, fatty acid glycerides such as tri (caprylic acid / capric acid) glycerin and glyceryl tricaprylate having a fatty acid ester structure in the molecule; fatty acid polyglycerides such as polyglyceryl-2 isostearate and polyglyceryl-2 triisostearate; soybean oil , Nuka oil, jojoba oil, avocado oil, almond oil, olive oil, cacao butter, sesame oil, persic oil, castor oil, coconut oil, mink oil, beef tallow, pork fat, and other natural fats and oils. Examples of the resulting oil include glycerides such as glyceryl myristate and glyceryl 2-ethylhexanoate. These fatty acid esters can be used alone or in combination of two or more.
造粒物(A)中の(a2)脂肪酸エステルの含有量は、0.1〜30質量%が好ましく、0.3〜15質量%がより好ましく、0.5〜8質量%がさらに好ましく、1〜5質量%が殊さらに好ましい。この範囲内であると、泡の微細化や発泡性に有効に作用すると共に高濃度の炭酸ガスを皮膚に供給しつつ、脂肪酸エステル自体が皮膚へ多量に吸着・浸透するため、高いしっとり感持続効果が得られ、一方で、造粒物の保形性も良好である。 The content of the (a2) fatty acid ester in the granulated product (A) is preferably 0.1 to 30% by mass, more preferably 0.3 to 15% by mass, further preferably 0.5 to 8% by mass, 1 to 5% by mass is particularly preferred. If it is within this range, it will effectively affect the fineness and foamability of the foam, and while supplying a high concentration of carbon dioxide to the skin, the fatty acid ester itself adsorbs and penetrates the skin in a large amount, thus maintaining a high moist feeling. The effect is obtained, while the shape retention of the granulated product is also good.
本発明で用いる(a3)非イオン界面活性剤は、(a2)脂肪酸エステルと共に使用することにより、本発明の浴用剤組成物を浴水に投入した場合に、(a2)脂肪酸エステルを浴湯中に均一に乳化させるとともにその(a2)脂肪酸エステル又は(a3)非イオン界面活性剤ミセル中に炭酸ガスを十分量溶解させることができ、脂肪酸エステルの皮膚への吸着や浸透を促進させるので好ましい。また(a3)非イオン界面活性剤は、特定の炭酸塩と共に使用することにより、極めて微細な炭酸ガスの泡を大量に発生させるので好ましい。 The (a3) nonionic surfactant used in the present invention is used together with the (a2) fatty acid ester, so that when the bath agent composition of the present invention is added to the bath water, the (a2) fatty acid ester is added to the bath water. It is preferable that a sufficient amount of carbon dioxide gas can be dissolved in the (a2) fatty acid ester or (a3) nonionic surfactant micelle, and the adsorption and penetration of the fatty acid ester into the skin is promoted. The (a3) nonionic surfactant is preferable because it generates a large amount of very fine bubbles of carbon dioxide gas when used with a specific carbonate.
このような非イオン界面活性剤としては、ショ糖脂肪酸エステル、グリセリン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビトール脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルケニルエーテル、ポリオキシエチレンポリオキシプロピレングリコール、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリオキシエチレンポリオキシプロピレンアルケニルエーテル、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ポリグリセリン脂肪酸エステル等が挙げられる。非イオン界面活性剤は1種でもよいが、2種以上用いることにより、上記効果をさらに向上させることができるため好ましい。 Such nonionic surfactants include sucrose fatty acid esters, glycerin fatty acid esters, propylene glycol fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene sorbitol fatty acid esters, polyoxyethylene alkyl ethers, polyoxyethylene alkenyl ethers. , Polyoxyethylene polyoxypropylene glycol, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene polyoxypropylene alkenyl ether, polyethylene glycol fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyglycerin fatty acid ester, etc. Is mentioned. One kind of nonionic surfactant may be used, but it is preferable to use two or more kinds since the above effect can be further improved.
非イオン界面活性剤としては、微細な炭酸ガスの泡を大量に発生させる点及び脂肪酸エステルの皮膚への吸着を促進させる点から、少なくともHLB10〜20の非イオン界面活性剤、特に、HLB12〜18の非イオン界面活性剤を用いるのが好ましい。造粒物(A)中の非イオン界面活性剤全量100質量部に対するHLB10〜20の非イオン界面活性剤の含有量は、30〜100質量部が好ましく、50〜100質量部がより好ましく、50〜90質量部がさらに好ましい。
ここで、HLBは、界面活性剤の親水性と疎水性のバランスを表すのに通常使用される値であり、当分野において慣用される川上式等の幾つかの計算式により求めることができる。本発明においては、下記の川上式を採用する。
HLB=7+11.7log(Mw/M0)
Mw:親水基の分子量
M0:疎水基の分子量
As the nonionic surfactant, at least HLB10-20 nonionic surfactants, particularly HLB12-18, from the viewpoint of generating a large amount of fine carbon dioxide bubbles and promoting the adsorption of fatty acid esters to the skin. It is preferable to use a nonionic surfactant. 30-100 mass parts is preferable, as for content of the nonionic surfactant of HLB10-20 with respect to 100 mass parts of nonionic surfactant whole quantity in a granulated material (A), 50-100 mass parts is more preferable, 50 -90 mass parts is further more preferable.
Here, HLB is a value normally used to represent the balance between the hydrophilicity and hydrophobicity of the surfactant, and can be obtained by several calculation formulas such as the Kawakami formula commonly used in this field. In the present invention, the following Kawakami equation is adopted.
HLB = 7 + 11.7log (Mw / M0)
Mw: Molecular weight of hydrophilic group M0: Molecular weight of hydrophobic group
これらの非イオン界面活性剤の中でも、ショ糖脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルケニルエーテル、ポリオキシエチレンソルビトール脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油等が好ましい。特に、ポリオキシエチレンアルキルエーテル及びポリオキシエチレンアルケニルエーテルから選ばれる1種以上の非イオン界面活性剤と、ポリオキシエチレンソルビトール脂肪酸エステル及びポリオキシエチレンソルビタン脂肪酸エステルから選ばれる1種以上の非イオン界面活性剤を組み合わせることが殊更好ましい。こうすることで、非イオン界面活性剤の上記効果のうち、特に、微細な炭酸ガスの泡の発生が著しく向上し、その結果、脂肪酸エステルの吸着性向上によるしっとり感持続効果が顕著に奏されるため、非常に好ましい。 Among these nonionic surfactants, sucrose fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene alkenyl ether, polyoxyethylene sorbitol fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene hydrogenated castor oil and the like are preferable. . In particular, at least one nonionic surfactant selected from polyoxyethylene alkyl ether and polyoxyethylene alkenyl ether, and at least one nonionic interface selected from polyoxyethylene sorbitol fatty acid ester and polyoxyethylene sorbitan fatty acid ester. It is particularly preferred to combine the activators. By doing this, among the above effects of the nonionic surfactant, in particular, the generation of fine carbon dioxide bubbles is remarkably improved, and as a result, the moist feeling sustaining effect due to the improved adsorption of fatty acid esters is remarkably exhibited. Therefore, it is very preferable.
造粒物(A)中の(a3)非イオン界面活性剤の含有量は、脂肪酸エステルと非イオン界面活性剤の合計量中、10〜70質量%が好ましく、特に20〜60質量%が好ましい。この範囲内であると、造粒物の保形性を保つという観点や、脂肪酸エステルを浴湯中に均一に乳化させると共に炭酸ガスの泡の微細化や発泡性に有効に作用する観点や、脂肪酸エステルの皮膚への吸着及び浸透が促進される観点から好ましい。 The content of the (a3) nonionic surfactant in the granulated product (A) is preferably 10 to 70 mass%, particularly preferably 20 to 60 mass%, in the total amount of the fatty acid ester and the nonionic surfactant. . Within this range, the viewpoint of maintaining the shape retention of the granulated product, the viewpoint of effectively emulsifying the fatty acid ester in the bath water, and effectively acting on the refinement and foaming of carbon dioxide gas bubbles, It is preferable from the viewpoint of promoting the adsorption and penetration of fatty acid esters into the skin.
本発明で用いる(a4)水溶性バインダーは、上記脂肪酸エステルや非イオン界面活性剤と共に用いられることで、造粒物の溶解性を制御して泡の微細化や発泡性に有効に作用すると共に、造粒物の強度を高める。また、有機酸が水溶性バインダーによって被覆されることで、保存中に造粒物(A)中の有機酸と炭酸塩が接触して、反応することが抑制され、炭酸ガスの発生により包装容器が膨張することを防止し、保存安定性を向上させることができる。 The water-soluble binder (a4) used in the present invention is used together with the fatty acid ester and the nonionic surfactant, thereby controlling the solubility of the granulated product and effectively acting on the finer foam and foamability. , Increase the strength of the granulate. In addition, the organic acid is coated with the water-soluble binder, so that the organic acid and the carbonate in the granulated product (A) are prevented from contacting and reacting during storage, and the packaging container is generated by the generation of carbon dioxide gas. Can be prevented from expanding, and the storage stability can be improved.
水溶性バインダーは、熱可塑性であることが好ましい。そのような水溶性バインダーとしては、ポリエチレングリコール、ポリプロピレングリコール、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンフェノールエーテルが好ましく、ポリエチレングリコール、ポリプロピレングリコールがさらに好ましい。 The water-soluble binder is preferably thermoplastic. As such a water-soluble binder, polyethylene glycol, polypropylene glycol, polyoxyethylene alkyl ether, and polyoxyethylene phenol ether are preferable, and polyethylene glycol and polypropylene glycol are more preferable.
また、水溶性バインダーの数平均分子量は、粉末化を行う際の粘度調整とハンドリング性の観点から、ポリスチレンを標準としたGPC法で、4,000〜20,000が好ましく、6,000〜13,000がより好ましく、7,000〜9,000がさらに好ましい。水溶性バインダーとして、ポリエチレングリコールの分子量を測定する場合には、溶媒として水/エタノールを用いた。 Further, the number average molecular weight of the water-soluble binder is preferably 4,000 to 20,000, preferably 6,000 to 13, by GPC method using polystyrene as a standard from the viewpoints of viscosity adjustment and handling properties when powdered. Is more preferable, and 7,000 to 9,000 is more preferable. When measuring the molecular weight of polyethylene glycol as a water-soluble binder, water / ethanol was used as a solvent.
また、これら水溶性バインダーを用いる場合には、数平均分子量の異なる水溶性バインダーを2種以上組み合わせて用いてもよい。 When these water-soluble binders are used, two or more water-soluble binders having different number average molecular weights may be used in combination.
造粒物(A)中の水溶性バインダーの含有量は、2〜30質量%が好ましく、5〜20質量%がより好ましい。前記下限値以上であると、造粒したときの粒子強度が高くなり、製造時の輸送過程で造粒物が壊れ難くなる。前記上限値以下であると、湯浴中での溶解性が向上し、微細発泡性が高められ、脂肪酸エステルの皮膚への吸着及び浸透が促進される。 2-30 mass% is preferable and, as for content of the water-soluble binder in granulated material (A), 5-20 mass% is more preferable. When the amount is not less than the lower limit, the particle strength when granulated is increased, and the granulated product is hardly broken during the transport process during production. When the amount is not more than the upper limit, the solubility in a hot water bath is improved, the fine foaming property is enhanced, and the adsorption and penetration of the fatty acid ester into the skin is promoted.
尚、本発明における造粒物(A)には、上記以外の成分であっても、本発明の課題を解決できる範囲内において、適宜配合することができる。そのような成分としては、(a2)脂肪酸エステル以外の油性成分、崩壊助剤、肌感触向上剤、消泡剤、酸化防止剤、分散剤、香料、防菌・防黴剤、色素、生薬類等が挙げられる。 In addition, even if it is a component other than the above in the granulated material (A) in this invention, it can mix | blend suitably in the range which can solve the subject of this invention. Examples of such components include (a2) oily components other than fatty acid esters, disintegration aids, skin feel improvers, antifoaming agents, antioxidants, dispersants, perfumes, antibacterial / antifungal agents, pigments, and crude drugs. Etc.
(a2)脂肪酸エステル以外の油性成分としては、炭酸ガスの油相/水相の分配比が1.1以上の(a2)脂肪酸エステル以外の油性成分を用いると、入浴後の温まり効果をさらに高めることができるため好ましい。より好ましい分配比は1.3以上であり、さらに好ましくは1.5以上であり、特に好ましくは1.6以上であり、さらに好ましくは1.7以上である。 (A2) As oily components other than fatty acid esters, when the oily component other than (a2) fatty acid esters has a carbon dioxide oil phase / water phase distribution ratio of 1.1 or more, the warming effect after bathing is further enhanced. This is preferable. A more preferable distribution ratio is 1.3 or more, further preferably 1.5 or more, particularly preferably 1.6 or more, and further preferably 1.7 or more.
このような油性成分としては、
流動パラフィン、ワセリン、パラフィン、マイクロクリスタリンワックス、セレシン、スクワラン、スクアレン、ジオクチルシクロヘキサン、ブリスタン等の炭化水素油;
ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、オレイン酸、リノール酸、リノレン酸、ラノリン酸、イソステアリン酸等の高級脂肪酸類;
ラウリルアルコール、セチルアルコール、ステアリルアルコール、オレイルアルコール、コレステロール、2−ヘキシルデカノール等の高級アルコール類;
ハッカ油、ジャスミン油、ショウ脳油、ヒノキ油、トウヒ油、リュウ油、テレピン油、ケイ皮油、ベルガモット油、ミカン油、ショウブ油、パイン油、ラベンダー油、ベイ油、クローブ油、ヒバ油、バラ油、ユーカリ油、レモン油、タイム油、ペパーミント油、ローズ油、セージ油、メントール、シネオール、オイゲノール、シトラール、シトロネラール、ボルネオール、リナロール、ゲラーオール、カンファー、チモール、スピラントール、ピネン、リモネン、テルペン系化合物等の精油;
シリコーン油類等が挙げられる。
As such an oil component,
Hydrocarbon oils such as liquid paraffin, petrolatum, paraffin, microcrystalline wax, ceresin, squalane, squalene, dioctylcyclohexane, bristan;
Higher fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, linoleic acid, linolenic acid, lanolinic acid, isostearic acid;
Higher alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, oleyl alcohol, cholesterol, 2-hexyldecanol;
Peppermint oil, jasmine oil, ginger brain oil, cypress oil, spruce oil, ryu oil, turpentine oil, cinnamon oil, bergamot oil, tangerine oil, ginger oil, pine oil, lavender oil, bay oil, clove oil, hiba oil, Rose oil, eucalyptus oil, lemon oil, thyme oil, peppermint oil, rose oil, sage oil, menthol, cineole, eugenol, citral, citronellal, borneol, linalool, gellerall, camphor, thymol, spirantol, pinene, limonene, terpene Essential oils such as compounds;
Examples thereof include silicone oils.
なお、炭酸ガスの油相/水相の分配比の測定方法は、後述の実施例に記載の方法により決定される。 In addition, the measuring method of the distribution ratio of the oil phase / water phase of carbon dioxide gas is determined by the method described in Examples described later.
造粒物(A)中の(a2)脂肪酸エステル以外の油性成分の含有量は、0.1〜30質量%が好ましく、0.15〜15質量%がより好ましい。前記下限値以上であると、温まり感及び肌感触感の観点から好ましく、前記上限値以下であると、油性成分を安定的に配合し、造粒物の保形性を保つ観点から好ましい。 0.1-30 mass% is preferable and, as for content of oil-based components other than (a2) fatty acid ester in granulated material (A), 0.15-15 mass% is more preferable. It is preferable from a viewpoint of a warm feeling and a skin feel as it is more than the said lower limit, and it is preferable from the viewpoint of stably mix | blending an oil-based component and maintaining the shape retention of a granulated material as it is below the said upper limit.
造粒物(A)中に、さらに、崩壊助剤を配合することにより、造粒物(A)の崩壊性を向上させ、湯浴中での溶解性を向上させることができる。崩壊助剤としては、常温(20℃)で固体の糖類や無機塩が好ましい。 By further adding a disintegration aid to the granulated product (A), the disintegration property of the granulated product (A) can be improved and the solubility in a hot water bath can be improved. As the disintegration aid, saccharides and inorganic salts which are solid at normal temperature (20 ° C.) are preferable.
糖類としては、ブドウ糖、果糖、乳糖、麦芽糖、蔗糖、デキストリン、マルトデキストリン、シクロデキストリン、マルトース、フルクトース、トレハロースが挙げられる。 Examples of the saccharide include glucose, fructose, lactose, maltose, sucrose, dextrin, maltodextrin, cyclodextrin, maltose, fructose, and trehalose.
無機塩としては、硫酸ナトリウム、硫酸マグネシウム、塩化ナトリウム、塩化カリウム、酸化マグネシウム、ポリ燐酸ナトリウム、燐酸ナトリウムが挙げられるが、無機塩として炭酸塩を含んでいても良いが、その場合は、造粒物(A)全体の15質量%未満、好ましくは、保存安定性の点から2質量%未満、特に好適には1質量%未満、さらに好適には0.5質量%未満であることが好ましい。殊更、炭酸塩は造粒物(A)中に含有しないことが保存安定性の観点から最も好ましい。 Examples of the inorganic salt include sodium sulfate, magnesium sulfate, sodium chloride, potassium chloride, magnesium oxide, sodium polyphosphate, and sodium phosphate. The inorganic salt may contain carbonate, but in that case, granulation is performed. The total amount of the product (A) is less than 15% by mass, preferably less than 2% by mass, particularly preferably less than 1% by mass, and more preferably less than 0.5% by mass from the viewpoint of storage stability. In particular, the carbonate is most preferably not contained in the granulated product (A) from the viewpoint of storage stability.
崩壊助剤の粒径は、造粒物(A)を製造する際の造粒性、泡の微細化、発泡性、及び浴水中での溶解性の観点から、平均粒径が1μm〜100μmであるものを用いることが好ましく、特に押出し造粒にて造粒する場合には、平均粒径が3μm〜50μmであるものを用いることがより好ましく、平均粒径が5μm〜30μmであるものを用いることがさらに好ましい。上記に示す粒径よりも大きい場合には、好適な粒度になるまで事前に解砕することが好ましい。なお、崩壊助剤の平均粒径は実施例に記載の測定方法により決定される。 The average particle size of the disintegration aid is 1 μm to 100 μm from the viewpoint of granulation, finer foam, foamability, and solubility in bath water when the granulated product (A) is produced. It is preferable to use a certain one, and in particular, when granulating by extrusion granulation, it is more preferable to use one having an average particle size of 3 μm to 50 μm, and one having an average particle size of 5 μm to 30 μm is used. More preferably. When the particle size is larger than the above, it is preferable to disintegrate in advance until a suitable particle size is obtained. The average particle size of the disintegration aid is determined by the measurement method described in the examples.
造粒物(A)中の崩壊助剤の含有量は、溶解性の観点から、0.1質量%〜15量%が好ましく、1質量%〜10質量%がより好ましい。 From the viewpoint of solubility, the content of the disintegration aid in the granulated product (A) is preferably 0.1% by mass to 15% by mass, and more preferably 1% by mass to 10% by mass.
造粒物(A)中に、さらに、肌感触向上剤を配合することで、入浴時の肌感触をさらに向上することもできる。そのような、肌感触向上剤としては、グリセリンやプロピレングリコールやソルビトール等の多価アルコールが好ましい。造粒物(A)中の、肌感触向上剤の含有量は、肌感触向上の観点から、0.01質量%〜1質量%、好ましくは0.1質量%〜0.5質量%が良い。 The skin feel at the time of bathing can further be improved by mix | blending a skin feel improvement agent in a granulated material (A) further. As such a skin feel improving agent, polyhydric alcohols such as glycerin, propylene glycol and sorbitol are preferable. The content of the skin feel-improving agent in the granulated product (A) is 0.01% by mass to 1% by mass, preferably 0.1% by mass to 0.5% by mass, from the viewpoint of improving the skin feel. .
造粒物(A)の嵩密度は、本発明の浴用剤組成物を浴湯に投与した際に、微細な炭酸ガスの発泡性を確保する観点から、700g/L以下であり、400〜700g/Lが好ましく、450〜650g/Lがより好ましい。本発明の嵩密度は、後述する(A)成分の製造時に圧密しすぎないことで達成できると考えられる。なお、(A)成分の造粒物の嵩密度はJIS K 3362により規定された方法により決定される。 The bulk density of the granulated product (A) is 700 g / L or less and 400 to 700 g from the viewpoint of securing the foamability of fine carbon dioxide gas when the bath agent composition of the present invention is administered to bath water. / L is preferable, and 450 to 650 g / L is more preferable. It is considered that the bulk density of the present invention can be achieved by not being too compact during the production of the component (A) described later. In addition, the bulk density of the granulated product of the component (A) is determined by a method defined by JIS K 3362.
造粒物(A)の粒径は、本発明の浴用剤組成物を使用した際の粉立ち性、及び浴湯に投与した際に、浴湯表面で発泡することを抑制する観点から180μm以下のものの割合は10質量%以下が好ましく、8質量%以下がより好ましく、6質量%以下がさらに好ましい。そして、造粒物(A)の粒径は、溶解性の観点から1400μm以上のものの割合は10質量%以下が好ましく、8質量%以下がより好ましく、6質量%以下がさらに好ましい。 The particle size of the granulated product (A) is 180 μm or less from the viewpoint of suppressing the foaming at the time of using the bath agent composition of the present invention and foaming on the bath water surface when administered to the bath water. The ratio of those is preferably 10% by mass or less, more preferably 8% by mass or less, and further preferably 6% by mass or less. And as for the particle size of a granulated material (A), 10 mass% or less is preferable from a soluble viewpoint, and 10 mass% or less is more preferable, 8 mass% or less is more preferable, and 6 mass% or less is further more preferable.
さらに、造粒物(A)の平均粒径は、粉立ち、溶解性及び沈降性の観点から、100〜1500μmが好ましく、400〜1200μmが好ましく、600〜900μmが好ましい。なお、造粒物(A)の平均粒径は実施例に記載の測定方法により決定される。 Furthermore, the average particle diameter of the granulated product (A) is preferably 100 to 1500 μm, preferably 400 to 1200 μm, and preferably 600 to 900 μm from the viewpoints of powdering, solubility and sedimentation. In addition, the average particle diameter of a granulated material (A) is determined by the measuring method as described in an Example.
本発明の浴用剤組成物中の造粒物(A)の含有量は、炭酸ガス発生量及び微細な炭酸ガスの泡を得る点から30〜80質量%が好ましく、さらに35〜75質量%、特に40〜70質量%が好ましい。 The content of the granulated product (A) in the bath agent composition of the present invention is preferably 30 to 80% by mass, more preferably 35 to 75% by mass, from the viewpoint of obtaining a carbon dioxide generation amount and fine carbon dioxide bubbles. 40-70 mass% is especially preferable.
本発明で用いる成分(B)の炭酸塩は炭酸ジアルカリ金属塩を含有し、且つ、炭酸水素塩を70質量以下%含有するものである。炭酸塩としては、炭酸ジアルカリ金属塩である炭酸ナトリウムや炭酸カリウム等;炭酸水素塩である炭酸水素ナトリウム等;二価以上の金属の炭酸塩である炭酸カルシウム等が挙げられる。炭酸ジアルカリ金属塩としては、炭酸ナトリウムが特に好ましく、炭酸水素塩としては、炭酸水素ナトリウムが特に好ましい。 The carbonate of the component (B) used in the present invention contains a dialkali metal carbonate and 70% by mass or less of hydrogen carbonate. Examples of the carbonate include sodium carbonate and potassium carbonate which are dialkali metal carbonates; sodium hydrogen carbonate which is a hydrogen carbonate; calcium carbonate which is a metal carbonate of a divalent or higher metal and the like. As the dialkali metal carbonate, sodium carbonate is particularly preferable, and as the hydrogen carbonate, sodium hydrogen carbonate is particularly preferable.
微細な炭酸ガスの泡を発生させる点で、成分(B)の炭酸塩中の炭酸水素塩の含有量は、0〜70質量%であり、さらに0.01〜70質量%、さらに0.1〜60質量%、特に1〜40質量%であることが好ましい。炭酸塩中の炭酸水素塩量が増加すると、炭酸ガスは白濁状を呈するような微細な炭酸ガスの泡にはならずに大きくなる傾向がある。しかしながら、本発明者らは、上記炭酸ガスの泡が大きくなってしまうという課題に対し、造粒物(A)中の非イオン界面活性剤と成分(B)中の炭酸ジアルカリ金属塩とを特定比率にすることで、極めて微細な泡を大量に発生させることが可能であることを見出した。 The content of the hydrogen carbonate in the carbonate of the component (B) is 0 to 70% by mass, further 0.01 to 70% by mass, and further 0.1 in terms of generating fine carbon dioxide bubbles. It is preferable that it is -60 mass%, especially 1-40 mass%. As the amount of hydrogen carbonate in the carbonate increases, the carbon dioxide gas tends to increase without becoming fine carbon dioxide bubbles that are cloudy. However, the present inventors specified a nonionic surfactant in the granulated product (A) and a dialkali metal carbonate in the component (B) for the problem that the bubbles of the carbon dioxide gas become large. It has been found that it is possible to generate a large amount of extremely fine bubbles by adjusting the ratio.
すなわち、造粒物(A)中の非イオン界面活性剤の含有量は、成分(B)中の炭酸ジアルカリ金属塩100質量部に対し、0.5〜30質量部が好ましく、1〜25質量部がより好ましく、2〜20質量部がさらに好ましく、3〜10質量部が殊更好ましい。造粒物(A)中の非イオン界面活性剤と成分(B)中の炭酸ジアルカリ金属塩との質量比がこの範囲内であると、極めて微細な炭酸ガスの泡の発生が著しく向上し、その結果、脂肪酸エステルの吸着性向上によるしっとり感の持続効果が顕著に奏され非常に好ましい。 That is, the content of the nonionic surfactant in the granulated product (A) is preferably 0.5 to 30 parts by mass, and 1 to 25 parts by mass with respect to 100 parts by mass of the dialkali metal carbonate in the component (B). Part is more preferable, 2 to 20 parts by mass is further preferable, and 3 to 10 parts by mass is particularly preferable. When the mass ratio of the nonionic surfactant in the granulated product (A) and the dialkali metal carbonate in the component (B) is within this range, the generation of extremely fine carbon dioxide bubbles is significantly improved, As a result, the effect of maintaining a moist feeling due to the improvement in the adsorptivity of the fatty acid ester is remarkably exhibited, which is very preferable.
成分(B)中の炭酸ジアルカリ金属塩の平均粒径は、泡の微細化、泡の持続時間、沈降性等の点から、100〜750μmが好ましく、さらに200〜500μm、特に250〜400μmであるのが好ましい。なお、成分(B)中の炭酸ジアルカリ金属塩の平均粒径は実施例に記載の測定方法により決定される。 The average particle diameter of the dialkali metal carbonate in the component (B) is preferably 100 to 750 μm, more preferably 200 to 500 μm, particularly 250 to 400 μm, from the viewpoints of finer foam, duration of foam, sedimentation and the like. Is preferred. In addition, the average particle diameter of the dialkali metal carbonate in the component (B) is determined by the measurement method described in the examples.
本発明の浴用剤組成物中の成分(B)である炭酸塩の含有量は、炭酸ガス発生量及び微細な炭酸ガスの泡を得る点から20〜70質量%が好ましく、さらに25〜60質量%、特に30〜50質量%が好ましい。 The content of the carbonate which is the component (B) in the bath agent composition of the present invention is preferably 20 to 70% by mass, and more preferably 25 to 60% by mass from the viewpoint of obtaining a carbon dioxide generation amount and fine carbon dioxide bubbles. %, Particularly 30 to 50% by mass is preferred.
本発明においては、本発明の効果を阻害しない範囲で、通常浴用剤に用いられている成分を成分(A)及び成分(B)を混合する際に成分(C)として添加することができる。このような成分としては、
ブドウ糖、果糖、乳糖、麦芽糖、蔗糖、デキストリン、マルトデキストリン、シクロデキストリン、マルトース、フルクトース、トレハロース等の糖類;
塩化ナトリウム、硫酸ナトリウム、硝酸カリウム、硝酸ナトリウム、硝酸カルシウム、ポリリン酸ナトリウム、塩化アンモニウム、硫酸鉄、燐酸ナトリウム、チオ硫酸ナトリウム、硼酸、メタ珪酸、無水珪酸、珪酸カルシウム、硫酸マグネシウム、塩化ナトリウム、塩化カリウム、酸化マグネシウム、ポリ燐酸ナトリウム等の無機塩類;
ソウジュツ、ビャクジュツ、カノコソウ、ケイガイ、コウボク、センキュウ、橙皮、トウキ、ショウキョウ末、ニンジン、ケイヒ、シャクヤク、ハッカ葉、オウゴン、サンシシ、ブクリョウ、ドクカツ、ショウブ、ガイヨウ、マツブサ、ビャクシ、ジュウヤク、リュウノウ、サフラン、オウバクエキス、チンピ、ウイキョウ、チンピ末、カミツレ、メリッサ、ローズマリー、マロニエ、西洋ノコギリ草、アルニカ等の生薬類;
エタノール、イソプロピルアルコール等のアルコール類;
グリセリン、プロピレングリコール、ソルビトール等の多価アルコール;
酸化チタン、酸化亜鉛、タルク、イオウ、鉱砂、湯の花、カゼイン、中性白土、サリチル酸ナトリウム、カルボキシメチルセルロースナトリウム、卵黄末、イリ糠、雲母末、脱脂粉乳、殺菌防腐剤、金属封鎖剤、香料、色素、生薬類その他製剤上必要な成分等が挙げられるが、これらに限定されるものではない。これらは、本発明の効果を阻害しない範囲であれば造粒物(A)中に配合しても良い。
In the present invention, the components usually used in bath preparations can be added as the component (C) when mixing the component (A) and the component (B) within a range not impairing the effects of the present invention. Such ingredients include:
Sugars such as glucose, fructose, lactose, maltose, sucrose, dextrin, maltodextrin, cyclodextrin, maltose, fructose, trehalose;
Sodium chloride, sodium sulfate, potassium nitrate, sodium nitrate, calcium nitrate, sodium polyphosphate, ammonium chloride, iron sulfate, sodium phosphate, sodium thiosulfate, boric acid, metasilicic acid, anhydrous silicic acid, calcium silicate, magnesium sulfate, sodium chloride, potassium chloride Inorganic salts such as magnesium oxide and sodium polyphosphate;
Sowjutsu, peanut, valerian, keigu, kokuboku, senkyu, orange peel, touki, ginger leaf, carrot, cinnamon, peonies, mint leaves, oxon, sushi, bukuryo, dokukatsu, shobu, gaiyou, matsubusa, juniper, jujube, cypress Herbal medicines such as saffron, duckweed extract, chimney, fennel, chimpi powder, chamomile, melissa, rosemary, maronier, sawtooth grass, arnica;
Alcohols such as ethanol and isopropyl alcohol;
Polyhydric alcohols such as glycerin, propylene glycol, sorbitol;
Titanium oxide, zinc oxide, talc, sulfur, mineral sand, hot spring flower, casein, neutral white clay, sodium salicylate, sodium carboxymethylcellulose, egg yolk powder, iri powder, mica powder, skim milk powder, bactericidal preservative, metal sequestering agent, fragrance, Examples include pigments, crude drugs, and other components necessary for the preparation, but are not limited thereto. You may mix | blend these in a granulated material (A), if it is a range which does not inhibit the effect of this invention.
本発明の粒状浴用剤組成物では、成分(A)及び成分(B)がそれぞれ独立の粒子状態で存在するものである。ここで「独立の粒子状態で存在する」とは、それぞれ独立した別個の粒子状態の成分(A)及び成分(B)が混在した状態で存在することを意味するものであり、粒状浴用剤中では、成分(A)及び成分(B)が混在しており、一般的に粉状や顆粒状と呼ばれるものである。 In the granular bath agent composition of the present invention, the component (A) and the component (B) are present in independent particle states. Here, “existing in an independent particle state” means that the component (A) and the component (B) in separate and independent particle states exist in a mixed state. Then, the component (A) and the component (B) are mixed and are generally called powder or granule.
本発明の粒状浴用剤組成物は、通常の造粒手段、すなわち、成分(A)に用いる各成分を適宜混合した後に押出造粒機や転動造粒機にて造粒することにより造粒物(A)を製造し、さらに、粒状の(B)炭酸塩及びその他の浴用剤組成物原料を混合することにより製造できる。 The granule bath agent composition of the present invention is granulated by normal granulation means, that is, granulation with an extrusion granulator or a tumbling granulator after appropriately mixing the components used for component (A). The product (A) can be produced, and further, the particulate (B) carbonate and other bath agent composition raw materials can be mixed.
本発明の粒状浴用剤組成物は、その0.01質量%水溶液の25℃におけるpHが5〜7、特に5.5〜6.5であることが好ましい。pHが5〜7であれば、発生した炭酸ガスが浴湯中に溶け込み易く、血行促進等の効果が高められるからである。 The granular bath agent composition of the present invention preferably has a 0.01 mass% aqueous solution having a pH of 5 to 7, particularly 5.5 to 6.5 at 25 ° C. This is because if the pH is 5 to 7, the generated carbon dioxide gas is easily dissolved in the bath water, and the effect of promoting blood circulation is enhanced.
本発明の粒状浴用剤組成物は、浴湯中に溶解した際に微細な炭酸ガスの泡が大量に発生する。微細な泡の発生は、浴湯180リットル中に40〜60gの本発明の入浴剤組成物を溶解した際に、発生した炭酸ガスの泡により、浴湯が速やかに白濁することから確認できる。この微細発泡の程度は、後述する実施例に記載の方法で測定する。 The granular bath agent composition of the present invention generates a large amount of fine carbon dioxide bubbles when dissolved in bath water. The generation of fine bubbles can be confirmed from the fact that the bath water quickly becomes cloudy due to the generated bubbles of carbon dioxide gas when 40 to 60 g of the bath agent composition of the present invention is dissolved in 180 liters of bath water. The degree of fine foaming is measured by the method described in the examples described later.
本発明の粒状浴用剤組成物は、浴湯に溶解し、炭酸ガスの泡を発生させて使用する。特に、炭酸ガスの泡が生じているうちに入浴するのが好ましい。すなわち、成分(A)有機酸、分子量が100以上でありClogP値が4〜18である脂肪酸エステル、非イオン界面活性剤及び水溶性バインダーを含む造粒物、及び、成分(B)炭酸ジアルカリ金属塩を含有し、且つ、炭酸水素塩を含まない或いは70質量%以下含有する炭酸塩、を含有する粒状浴用剤組成物を浴水に投入して発泡を開始せしめ、発泡中又は発泡後浴水中に泡が残存している浴水に、身体の少なくとも一部を浸漬するスキンケア方法であれば、本発明の効果が特に顕著に奏される。なお、本発明の浴用剤組成物は風呂等の全身浴はもちろん、足浴、腕浴等の部分浴としても使用できる。 The granular bath agent composition of the present invention is used by dissolving in bath water and generating bubbles of carbon dioxide gas. It is particularly preferable to take a bath while carbon dioxide bubbles are generated. That is, a granulated product containing a component (A) organic acid, a fatty acid ester having a molecular weight of 100 or more and a ClogP value of 4 to 18, a nonionic surfactant and a water-soluble binder, and component (B) dialkali metal carbonate A granular bath agent composition containing a salt and a carbonate containing no bicarbonate or 70% by mass or less is introduced into bath water to start foaming, and bathing during foaming or after foaming If the skin care method involves immersing at least a part of the body in bath water in which bubbles remain, the effects of the present invention are particularly prominent. The bath agent composition of the present invention can be used not only for a whole body bath such as a bath, but also as a partial bath such as a foot bath and an arm bath.
<粒径>
粒径については、以下の2つの方法により測定した。
(1)造粒物(A)及び炭酸ジアルカリ金属塩の粒径は、JIS K 8801の標準篩(目開き2000〜125μm)を用いて5分間振動させた後、篩目のサイズによる重量分率からメジアン径を算出した。
より詳細には、目開き125μm、180μm、250μm、355μm、500μm、710μm、1000μm、1400μm、2000μmの9段の篩と受け皿を用いて、受け皿上に目開きの小さな篩から順に積み重ね、最上部の2000μmの篩の上から100gの粒子を添加し、蓋をしてロータップ型ふるい振とう機(HEIKO製作所製、タッピング156回/分、ローリング:290回/分)に取り付け、5分間振動させたあと、それぞれの篩及び受け皿上に残留した該粒子の質量を測定し、各篩上の該粒子の質量割合(%)を算出した。
<Particle size>
The particle size was measured by the following two methods.
(1) The particle size of the granulated product (A) and the dialkali metal carbonate is a weight fraction according to the size of the sieve mesh after vibrating for 5 minutes using a standard sieve (mesh 2000 to 125 μm) of JIS K 8801. From the above, the median diameter was calculated.
More specifically, using a 9-stage sieve and a tray with a mesh opening of 125 μm, 180 μm, 250 μm, 355 μm, 500 μm, 710 μm, 1000 μm, 1400 μm, and 2000 μm, the top of the top is stacked in order from the small sieve. Add 100 g of particles from the top of a 2000 μm sieve, cover and attach to a low-tap type sieve shaker (manufactured by HEIKO, tapping 156 times / minute, rolling: 290 times / minute), and shake for 5 minutes. The mass of the particles remaining on each sieve and the tray was measured, and the mass ratio (%) of the particles on each sieve was calculated.
崩壊助剤の平均粒径測定は、レーザー回折/散乱式粒度分布測定装置LA−920(堀場製作所(株)製)を用い、該粒子を溶解させない溶媒に分散させて測定したメジアン径を平均粒径とした。尚、実施例に用いたフマル酸及び崩壊助剤の平均粒径測定には、溶媒としてアセトンを用いた。 The average particle size of the disintegration aid was measured using a laser diffraction / scattering particle size distribution analyzer LA-920 (manufactured by Horiba, Ltd.) and the median diameter measured by dispersing the particles in a solvent that did not dissolve the particles. The diameter. In addition, acetone was used as a solvent for the average particle diameter measurement of the fumaric acid and disintegration aid used in the examples.
<吸油能>
有機酸の吸油能測定は以下の方法で行った。吸収量測定器(あさひ総研製S410)に粉末を45g投入し、駆動羽根200rpmで回転させた。ここに油性成分及び非イオン界面活性剤を溶解した50℃混合液(花王(株)製エキセパールIPP 50質量%、花王(株)製エキセパールO−DM 15質量%、花王(株)製ルナックBA 5質量%、花王(株)製エマルゲン306P 10質量%、日光ケミカルズ(株)製ニッコールGO―440V 20質量%)を、液供給速度2mL/minで滴下し、最大トルクとなる点を見極めた。この最大トルクとなる点の70%のトルクとなる点での液添加量を粉末投入量で除算し、吸油能とした。
<Oil absorption capacity>
The oil absorption capacity of the organic acid was measured by the following method. 45 g of powder was put into an absorption measuring device (A410 manufactured by Asahi Research Institute) and rotated at a driving blade of 200 rpm. 50 ° C. mixed solution in which an oil component and a nonionic surfactant are dissolved (Exepal IPP 50% by mass, Kao Corp. Exepar O-DM 15% by mass, Lunac BA 5 manufactured by Kao Corp.) 10% by mass, 10% by mass of Emulgen 306P manufactured by Kao Corporation, and 20% by mass of Nikkor GO-440V manufactured by Nikko Chemicals Co., Ltd. were dropped at a liquid supply rate of 2 mL / min to determine the point at which the maximum torque was obtained. The liquid addition amount at the point where the torque becomes 70% of the point where the maximum torque is reached is divided by the amount of powder input to obtain the oil absorption capacity.
<炭酸ガスの油相/水相への分配比の測定方法> <Measurement method of distribution ratio of carbon dioxide gas to oil phase / water phase>
炭酸ガスの分配操作は以下の方法で25℃の常温下にて行った。油剤2mLとイオン交換水8mLを15mLのスクリュー管に入れ、管底部にノズルを挿入し4分間炭酸ガスを十分量連続注入した。注入停止後、上層に油層が形成されたら速やかに油層を採取し、炭酸ガス測定サンプルとした。次にスクリュー管底部にピペットを静かに挿入して水相を採取し、炭酸ガス測定サンプルとした。
炭酸ガス濃度の測定には、ATR−IR法を用いた。炭酸ガスのIRスペクトルは2350cm-1付近に強い吸収を示すことが知られており、この吸収は振動モードとしては、1つであるが、気体の場合、回転の遷移が重畳するため、分解能の低い設定で測定すると見かけ上、2本の吸収に分裂して観測されるが、炭酸ガスが液体に溶解した場合、回転が制限されるため、1本の吸収帯として観測され、この違いから気体と液体に溶解した炭酸ガスが識別される。
測定条件装置:パーキンエルマー SpectrumOne/ユニバーサルATRユニット
分解能:16cm-1
スキャン回数:16回(約25秒)
大気補正機能:OFF
測定順序:油剤バックグラウンド測定→油相の測定→水のバックグラウンド測定→水相の測定
Carbon dioxide gas was distributed at room temperature of 25 ° C. by the following method. 2 mL of oil and 8 mL of ion exchange water were placed in a 15 mL screw tube, a nozzle was inserted into the bottom of the tube, and a sufficient amount of carbon dioxide gas was continuously injected for 4 minutes. After stopping the injection, when an oil layer was formed in the upper layer, the oil layer was immediately collected and used as a carbon dioxide measurement sample. Next, a pipette was gently inserted into the bottom of the screw tube to collect an aqueous phase, which was used as a carbon dioxide measurement sample.
The ATR-IR method was used for measuring the carbon dioxide concentration. The IR spectrum of carbon dioxide gas is known to exhibit strong absorption near 2350 cm −1 , and this absorption is one vibration mode, but in the case of gas, since the rotational transition is superimposed, When measured at a low setting, it is observed that it splits into two absorptions, but when carbon dioxide dissolves in the liquid, rotation is limited, so it is observed as one absorption band. And carbon dioxide dissolved in the liquid is identified.
Measuring condition apparatus: Perkin Elmer SpectrumOne / Universal ATR unit Resolution: 16 cm -1
Number of scans: 16 times (about 25 seconds)
Atmospheric correction function: OFF
Measurement sequence: Oil background measurement → Oil phase measurement → Water background measurement → Water phase measurement
実施例1〜6、比較例1〜4
表1に示す成分(A)に用いる成分を混合後押出造粒機にて造粒し、(B)成分、さらに他の成分を混合して、粒状発泡性浴用剤を製造した。
Examples 1-6, Comparative Examples 1-4
After mixing the component used for the component (A) shown in Table 1, it granulated with the extrusion granulator, (B) component and another component were mixed, and the granular foaming bath agent was manufactured.
比較例2
表1に示す成分(A)、成分(B)及びその他成分を全て混合した後、理研社製油圧プレス(型番:CD−50−135B)により、直径55mm、厚さ15mmの円柱状の打錠物(1錠45g)にした。
Comparative Example 2
After all the components (A), (B) and other components shown in Table 1 are mixed, a cylindrical tablet having a diameter of 55 mm and a thickness of 15 mm is obtained with a hydraulic press (model number: CD-50-135B) manufactured by Riken. (1 tablet 45g).
比較例3
表1に示す配合で各成分を混合し、液体状浴用剤を得た。
Comparative Example 3
Each component was mixed by the mixing | blending shown in Table 1, and the liquid bath agent was obtained.
得られた実施例1〜6、比較例1〜4の浴用剤組成物について、浴水に溶解した際の泡状態、使用感を評価し、結果を合わせて表1に示す。 About the obtained bath agent composition of Examples 1-6 and Comparative Examples 1-4, the foam state at the time of melt | dissolving in bath water and a usability | use_condition are evaluated, and a result is shown in Table 1.
<浴用剤組成物の評価方法> <Evaluation method of bath agent composition>
〔微細発泡の程度(濁度)〕
浴槽に40℃180Lのお湯を入れ、浴用剤組成物を投入し、十分攪拌し、直径5cmの円形の黒色ゴム板を浴水に沈め、肉眼で完全に見えなくなる深度をにごり度(濁度)とし測定した。深度の数値(cm)が小さいほど、より微細な泡が生じていることを示す。
[Degree of fine foaming (turbidity)]
Put hot water of 40 ℃ 180L in the bathtub, add the bath agent composition, stir well, submerge a circular black rubber plate with a diameter of 5cm in the bath water, turbidity to a depth that is completely invisible to the naked eye (turbidity) And measured. It shows that the finer bubble has arisen, so that the numerical value (cm) of depth is small.
(1)入浴後のしっとり感持続の評価
20〜40才の女性合計10名のパネラーにより評価した。浴槽に40℃180Lのお湯を入れ、浴用剤組成物を投入した後、速やかにパネラーを入浴させ、出浴30分後のしっとり感を下記の基準で評価し、10名の平均値を評価点とした。
5:しっとりする。
4:ややしっとりする。
3:どちらとも言えない。
2:あまりしっとりしない。
1:しっとりしない。
(1) Evaluation of persistence of moist feeling after bathing Evaluation was made by a total of 10 panelists of 20 to 40 year old women. After putting hot water of 40L at 40 ° C into the bathtub and putting the bath preparation composition, the paneler is quickly bathed, the moist feeling after 30 minutes of bathing is evaluated according to the following criteria, and the average value of 10 people is evaluated It was.
5: Moist.
4: Slightly moist.
3: I can't say either.
2: Not very moist.
1: Not moist.
(2)入浴後の温まり感の評価
20〜40才の女性合計10名のパネラーにより評価した。浴槽に40℃180Lのお湯を入れ、浴用剤組成物を投入した後、速やかにパネラーを入浴させ、入浴直後の温まり感を下記の基準で評価し、10名の平均値を評価点とした。
5:温まる。
4:やや温まる。
3:さら湯と同等。
2:さら湯と比べてやや温まらない。
1:さら湯と比べて温まらない。
(2) Evaluation of warmth feeling after bathing Evaluation was made by a total of 10 panelists of 20 to 40 year old women. After putting hot water of 40 L at 40 ° C. into the bathtub and introducing the bath agent composition, the paneler was quickly bathed, and the warmth feeling immediately after bathing was evaluated according to the following criteria, and the average value of 10 persons was used as the evaluation score.
5: Warm up.
4: Slightly warms up.
3: Equivalent to Sarayu.
2: It does not warm a little compared with Sarayu.
1: Not warm compared with Sarayu.
表1より、本発明の浴用剤組成物を用いれば、微細な炭酸ガスの泡が大量に発生し、浴後の温まり感に優れることに留まらず、脂肪酸エステルの皮膚への吸着・浸透量が著しく向上し、皮膚の水分保持能も著しく向上するため浴後の過乾燥を抑制でき、入浴後の肌のしっとり感が著しく持続する。 From Table 1, if the bath preparation composition of the present invention is used, a large amount of fine carbon dioxide bubbles are generated, and it is not only excellent in the feeling of warming after the bath, but also the amount of adsorption / penetration of fatty acid ester into the skin is remarkable. And the moisture retention ability of the skin is remarkably improved, so that overdrying after bathing can be suppressed, and the moist feeling of the skin after bathing is remarkably sustained.
Claims (4)
(A)有機酸、分子量が100以上でありClogP値が4〜18である脂肪酸エステル、非イオン界面活性剤及び水溶性バインダーを含む造粒物、並びに
(B)炭酸ジアルカリ金属塩を含有し、且つ、炭酸水素塩を70質量%以下含有する炭酸塩
を含有する粒状浴用剤組成物。 The following components (A) and (B):
(A) an organic acid, a granule containing a fatty acid ester having a molecular weight of 100 or more and a ClogP value of 4 to 18, a nonionic surfactant and a water-soluble binder, and (B) containing a dialkali metal carbonate, And the granular bath agent composition containing the carbonate containing 70 mass% or less of hydrogencarbonate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010158924A JP5534988B2 (en) | 2010-07-13 | 2010-07-13 | Granular bath agent composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010158924A JP5534988B2 (en) | 2010-07-13 | 2010-07-13 | Granular bath agent composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012020951A JP2012020951A (en) | 2012-02-02 |
JP5534988B2 true JP5534988B2 (en) | 2014-07-02 |
Family
ID=45775517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010158924A Active JP5534988B2 (en) | 2010-07-13 | 2010-07-13 | Granular bath agent composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5534988B2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5727214B2 (en) * | 2010-12-22 | 2015-06-03 | 花王株式会社 | Granular bath agent composition |
JP6207873B2 (en) * | 2012-04-27 | 2017-10-04 | 花王株式会社 | Bath agent composition |
JP6095963B2 (en) * | 2012-12-07 | 2017-03-15 | 花王株式会社 | Fragrance granule |
JP6008118B2 (en) * | 2012-12-14 | 2016-10-19 | 山栄化学株式会社 | Wave agent second agent and wave agent |
JP6096018B2 (en) * | 2013-03-21 | 2017-03-15 | 花王株式会社 | Bathing agent for reducing dead temperature |
JP6184758B2 (en) * | 2013-06-04 | 2017-08-23 | 花王株式会社 | Foot arch collapse improver |
JP6301623B2 (en) * | 2013-10-02 | 2018-03-28 | 花王株式会社 | Granular bath agent composition |
JP6881928B2 (en) * | 2016-09-27 | 2021-06-02 | 花王株式会社 | Effervescent tablet bath composition |
KR102587270B1 (en) * | 2017-04-04 | 2023-10-11 | 카오카부시키가이샤 | body cosmetics |
JP6400804B2 (en) * | 2017-08-09 | 2018-10-03 | 花王株式会社 | Powder bath composition |
JP2020537549A (en) * | 2017-08-18 | 2020-12-24 | シムライズ アーゲー | Air freshener release composition |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2516249B2 (en) * | 1988-10-25 | 1996-07-24 | 花王株式会社 | Bath additive |
JP4313230B2 (en) * | 2003-08-26 | 2009-08-12 | 花王株式会社 | Bath agent composition |
JP4504729B2 (en) * | 2004-04-27 | 2010-07-14 | 花王株式会社 | Two-component bath agent |
JP5285210B2 (en) * | 2006-02-22 | 2013-09-11 | 花王株式会社 | Bath additive |
JP5072580B2 (en) * | 2007-12-25 | 2012-11-14 | 花王株式会社 | Granular bath agent composition |
JP2009263311A (en) * | 2008-04-28 | 2009-11-12 | Kao Corp | Skin care method |
-
2010
- 2010-07-13 JP JP2010158924A patent/JP5534988B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2012020951A (en) | 2012-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5534988B2 (en) | Granular bath agent composition | |
JP5719532B2 (en) | Method for producing foamable powder bath composition | |
JP5883655B2 (en) | Method for producing foaming bath agent composition | |
JP5727214B2 (en) | Granular bath agent composition | |
JP5441529B2 (en) | Granular foam bath agent | |
KR102198260B1 (en) | Liquid drop releasing cosmetic | |
JP5412220B2 (en) | Organic acid-containing granules | |
JP6629652B2 (en) | Effervescent tablet type bath composition | |
JP2012001469A (en) | Method for manufacturing granulated substance for bathing agent | |
JP5670660B2 (en) | Bath agent composition | |
JP6829621B2 (en) | Bath preparation composition | |
JP2012072126A (en) | Thermoregulatory function improving agent | |
JP2012144474A (en) | Method for manufacturing bubbling powder bathing agent composition | |
JP2013139396A (en) | Solid bathing agent | |
JP6320017B2 (en) | Bath agent composition | |
JP5291922B2 (en) | Lipophilic component-containing powder | |
JP6617064B2 (en) | Bath agent composition | |
JP6829620B2 (en) | Solid bath salt | |
JP2013095709A (en) | Bathing agent for improving basal metabolism | |
JP2015071550A (en) | Granular bath agent composition | |
JP2014201540A (en) | Bathing agent composition | |
JP6411779B2 (en) | Bath agent composition | |
JP2016193890A (en) | Effervescent external preparation for skin | |
JP5945133B2 (en) | Bath agent composition | |
JP6617052B2 (en) | Carbon dioxide foaming bath composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130712 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140327 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140401 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140422 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5534988 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |